15-98649596-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_000875.5(IGF1R):c.15C>T(p.Ser5=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000549 in 1,598,454 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0032 ( 6 hom., cov: 32)
Exomes 𝑓: 0.00028 ( 0 hom. )
Consequence
IGF1R
NM_000875.5 synonymous
NM_000875.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.991
Genes affected
IGF1R (HGNC:5465): (insulin like growth factor 1 receptor) This receptor binds insulin-like growth factor with a high affinity. It has tyrosine kinase activity. The insulin-like growth factor I receptor plays a critical role in transformation events. Cleavage of the precursor generates alpha and beta subunits. It is highly overexpressed in most malignant tissues where it functions as an anti-apoptotic agent by enhancing cell survival. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, May 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.42).
BP6
Variant 15-98649596-C-T is Benign according to our data. Variant chr15-98649596-C-T is described in ClinVar as [Benign]. Clinvar id is 718201.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.991 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00322 (478/148374) while in subpopulation AFR AF= 0.0115 (457/39888). AF 95% confidence interval is 0.0106. There are 6 homozygotes in gnomad4. There are 219 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 6 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IGF1R | NM_000875.5 | c.15C>T | p.Ser5= | synonymous_variant | 1/21 | ENST00000650285.1 | NP_000866.1 | |
IRAIN | NR_126453.2 | n.1192G>A | non_coding_transcript_exon_variant | 1/1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IGF1R | ENST00000650285.1 | c.15C>T | p.Ser5= | synonymous_variant | 1/21 | NM_000875.5 | ENSP00000497069 | P4 | ||
IGF1R | ENST00000559925.5 | n.15C>T | non_coding_transcript_exon_variant | 1/10 | 1 | |||||
IGF1R | ENST00000649865.1 | c.15C>T | p.Ser5= | synonymous_variant | 1/21 | ENSP00000496919 | A1 |
Frequencies
GnomAD3 genomes AF: 0.00322 AC: 478AN: 148308Hom.: 6 Cov.: 32
GnomAD3 genomes
AF:
AC:
478
AN:
148308
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000817 AC: 201AN: 246124Hom.: 0 AF XY: 0.000561 AC XY: 75AN XY: 133752
GnomAD3 exomes
AF:
AC:
201
AN:
246124
Hom.:
AF XY:
AC XY:
75
AN XY:
133752
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000276 AC: 400AN: 1450080Hom.: 0 Cov.: 31 AF XY: 0.000224 AC XY: 162AN XY: 721962
GnomAD4 exome
AF:
AC:
400
AN:
1450080
Hom.:
Cov.:
31
AF XY:
AC XY:
162
AN XY:
721962
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00322 AC: 478AN: 148374Hom.: 6 Cov.: 32 AF XY: 0.00303 AC XY: 219AN XY: 72198
GnomAD4 genome
AF:
AC:
478
AN:
148374
Hom.:
Cov.:
32
AF XY:
AC XY:
219
AN XY:
72198
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2023 | IGF1R: BP4, BP7, BS1, BS2 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at